Literature DB >> 10202145

DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

S Y Shieh1, Y Taya, C Prives.   

Abstract

Upon DNA damage, p53 has been shown to be modified at a number of N-terminal phosphorylation sites including Ser15 and -33. Here we show that phosphorylation is induced as well at a novel site, Ser20. Phosphorylation at Ser15, -20 and -33 can occur within minutes of DNA damage. Interestingly, while the DNA-binding activities of p53 appear to be dispensable, efficient phosphorylation at these three sites requires the tetramerization domain of p53. Substitution of an artificial tetramerization domain for this region also permits phosphorylation at the N-terminus, suggesting that oligomerization is important for DNA damage-induced signalling to p53.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202145      PMCID: PMC1171267          DOI: 10.1093/emboj/18.7.1815

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  71 in total

1.  Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.

Authors:  Y Wang; C Prives
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

2.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

3.  p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

Authors:  C A Midgley; D P Lane
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

Review 4.  p53: a cell cycle regulator activated by DNA damage.

Authors:  G Selivanova; K G Wiman
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

5.  Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo.

Authors:  S Jamal; E B Ziff
Journal:  Oncogene       Date:  1995-06-01       Impact factor: 9.867

6.  Solution structure of the tetrameric minimum transforming domain of p53.

Authors:  W Lee; T S Harvey; Y Yin; P Yau; D Litchfield; C H Arrowsmith
Journal:  Nat Struct Biol       Date:  1994-12

7.  The polyproline region of p53 is required to activate apoptosis but not growth arrest.

Authors:  D Sakamuro; P Sabbatini; E White; G C Prendergast
Journal:  Oncogene       Date:  1997-08-18       Impact factor: 9.867

8.  Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.

Authors:  G A Mayr; M Reed; P Wang; Y Wang; J F Schweds; P Tegtmeyer
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

9.  p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts.

Authors:  J Renzing; D P Lane
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

10.  Refined solution structure of the oligomerization domain of the tumour suppressor p53.

Authors:  G M Clore; J Ernst; R Clubb; J G Omichinski; W M Kennedy; K Sakaguchi; E Appella; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1995-04
View more
  92 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 3.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

4.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

5.  The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest.

Authors:  S Wang; M Guo; H Ouyang; X Li; C Cordon-Cardo; A Kurimasa; D J Chen; Z Fuks; C C Ling; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Authors:  Y Nie; H H Li; C M Bula; X Liu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

7.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Authors:  E Kobet; X Zeng; Y Zhu; D Keller; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 8.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

9.  WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase.

Authors:  Fei Su; Michael Overholtzer; Daniel Besser; Arnold J Levine
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

10.  The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.

Authors:  J T Zilfou; W H Hoffman; M Sank; D L George; M Murphy
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.